Tuning the Cytotoxicity of Bis-Phosphino-Amines Ruthenium(II) Para-Cymene Complexes for Clinical Development in Breast Cancer

Despite some limitations such as long-term side effects or the potential presence of intrinsic or acquired resistance, platinum compounds are key therapeutic components for the treatment of several solid tumors. To overcome these limitations, maintaining the same efficacy, organometallic ruthenium(I...

Descripción completa

Detalles Bibliográficos
Autores principales: Domínguez-Jurado, Elena, Cimas, Francisco J., Castro-Osma, José Antonio, Juan, Alberto, Lara-Sánchez, Agustín, Rodríguez-Diéguez, Antonio, Shafir, Alexandr, Ocaña, Alberto, Alonso-Moreno, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539368/
https://www.ncbi.nlm.nih.gov/pubmed/34683852
http://dx.doi.org/10.3390/pharmaceutics13101559

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539368/
https://www.ncbi.nlm.nih.gov/pubmed/34683852
http://dx.doi.org/10.3390/pharmaceutics13101559

Ejemplares similares